You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 28, 2025

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Melissa A Durand1, Sarah M Friedewald1, Donna M Plecha1
1From the Department of Diagnostic Radiology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510 (M.A.D.); Advocate Lutheran General Hospital, Park Ridge, Ill (S.M.F., F.M.D.); Department of Radiology, University Hospitals of Cleveland Medical Center, Cleveland, Ohio (D.M.P.); Albert Einstein Healthcare Network, Philadelphia, Pa (D.S.C.); Invision Sally Jobe Breast Centers and Radiology Imaging Associates, Denver, Colo (L.D.B.); TOPS Comprehensive Breast Center, Houston, Tex (S.L.R.); Solis Women's Health, Dallas, Tex (S.L.R.); Radiology Associates of Hollywood and Memorial Healthcare System, Hollywood, Fla (M.K.H.); John C. Lincoln Breast Health and Research Center, Phoenix, Ariz (L.N.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa (E.F.C.).
Digital breast tomosynthesis (DBT) screening shows improved accuracy over digital mammography (DM), detecting more invasive cancers with fewer advanced markers. This advancement in breast cancer screening offers better diagnostic performance and potentially improved patient outcomes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: